These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16888617)

  • 1. The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.
    Bensinger WI
    Leukemia; 2006 Oct; 20(10):1683-9. PubMed ID: 16888617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current status of hematopoietic stem cell transplantation for multiple myeloma.
    Bensinger WI
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in hematopoietic stem cell transplantation for multiple myeloma.
    Bensinger WI
    Int J Hematol; 2003 Apr; 77(3):232-8. PubMed ID: 12731665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there still a role for allogeneic stem-cell transplantation in multiple myeloma?
    Bensinger WI
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):783-95. PubMed ID: 18070719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation for multiple myeloma.
    Bensinger WI; Maloney D; Storb R
    Semin Hematol; 2001 Jul; 38(3):243-9. PubMed ID: 11486312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced intensity allogeneic stem cell transplantation in multiple myeloma.
    Bensinger WI
    Front Biosci; 2007 May; 12():4384-92. PubMed ID: 17485382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation for multiple myeloma.
    Bensinger WI
    Biomed Pharmacother; 2002 May; 56(3):133-8. PubMed ID: 12046684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.
    Bensinger WI
    J Natl Compr Canc Netw; 2004 Jul; 2(4):371-8. PubMed ID: 19795599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
    Zeiser R; Finke J
    Eur J Cancer; 2006 Jul; 42(11):1601-11. PubMed ID: 16759847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic.
    Mir MA; Kapoor P; Kumar S; Pandey S; Dispenzieri A; Lacy MQ; Dingli D; Hogan W; Buadi F; Hayman S; Gandhi M; Gertz MA
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):349-357.e2. PubMed ID: 25958193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in allogeneic transplantation for multiple myeloma.
    Gahrton G
    Eur J Haematol; 2010 Oct; 85(4):279-89. PubMed ID: 20608964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
    Koehne G; Giralt S
    Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
    Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.
    Salit RB; Bishop MR
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):247-52. PubMed ID: 21658650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.